The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation
Patients with lung cancer often present with metastatic disease and therefore have a very poor prognosis. The recent discovery of several novel ROS receptor tyrosine kinase molecular alterations in non-small cell lung cancer (NSCLC) presents a therapeutic opportunity for the development of new targe...
Main Authors: | , , , , , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research,
2014-08-25T18:11:49Z.
|
Subjects: | |
Online Access: | Get fulltext |